{"id":"W2571097605","doi":"10.1016/j.jtho.2016.11.514","title":"MA16.11 CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC: Pooled Data from Two Phase II Trials","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Osimertinib; Medicine; Internal medicine; Oncology; T790M; Clinical trial; Population; Target lesion; Cancer; Epidermal growth factor receptor; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"grok","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"opus","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001578061,0.0001836554,0.001033572,0.0002510878,0.0002210007,0.00003582767,0.0004277639,0.00009630863,0.00015239],"category_scores_gemma":[0.002595639,0.0001218371,0.00009441668,0.0001045032,0.00007593184,0.0004392314,0.0001788001,0.0002720654,0.00001538195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005072902,"about_ca_system_score_gemma":0.001018825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001333682,"about_ca_topic_score_gemma":0.000241521,"domain_scores_codex":[0.9977234,0.0005652809,0.0008410024,0.0002932334,0.0003223666,0.0002547092],"domain_scores_gemma":[0.9965304,0.0006465358,0.001353804,0.0008023049,0.0003784895,0.0002885018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3685036,0.006854498,0.05362102,0.00001472115,0.001651141,0.001535044,0.002683192,0.0000495155,0.006279214,0.000006224175,0.002716638,0.5560852],"study_design_scores_gemma":[0.1079772,0.03760167,0.8071068,0.001273071,0.004706888,0.00009568881,0.0006557446,0.0000560562,0.00375232,0.0001449776,0.03629247,0.0003370735],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868712,0.0001686448,0.0002873485,0.01023407,0.0005696092,0.0008197533,0.0005043456,0.000007602154,0.0005373867],"genre_scores_gemma":[0.9890921,0.00001575727,0.009276417,0.0007103119,0.0003163161,0.00001424221,0.0001438214,0.00002434796,0.0004067155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7534858,"threshold_uncertainty_score":0.4968372,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05776611874330057,"score_gpt":0.5222276652436241,"score_spread":0.4644615465003235,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}